Beam Therapeutics Inc. (BMV:BEAM)
494.00
+14.00 (2.92%)
At close: Oct 9, 2025
Beam Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -398.58 | -376.74 | -132.53 | -289.09 | -370.64 | -194.59 | Upgrade |
Depreciation & Amortization | 21.98 | 31.59 | 29.53 | 22.58 | 7.45 | 4.74 | Upgrade |
Stock-Based Compensation | 110.83 | 120.66 | 98.65 | 84.32 | 43.57 | 15.38 | Upgrade |
Other Adjustments | -20.34 | -12.54 | -28.39 | -46.91 | 142.1 | 73.39 | Upgrade |
Change in Receivables | - | - | -0.15 | 300 | -300 | - | Upgrade |
Changes in Accounts Payable | 5.19 | 1.81 | -7.58 | 2.37 | 0.82 | 0.06 | Upgrade |
Changes in Accrued Expenses | -22.51 | -57.69 | 67.66 | -16.93 | 43.91 | 7.04 | Upgrade |
Changes in Unearned Revenue | -34.27 | -36.52 | -159.56 | -35.92 | 348.16 | - | Upgrade |
Changes in Other Operating Activities | -16.78 | -17.83 | -16.84 | 2.11 | 18.37 | -1.75 | Upgrade |
Operating Cash Flow | -344.82 | -347.25 | -149.2 | 22.53 | -66.27 | -95.74 | Upgrade |
Capital Expenditures | -10.75 | -8.95 | -33.73 | -48.95 | -46.81 | -16.36 | Upgrade |
Purchases of Investments | - | -486.44 | -984.34 | -1,617 | -777.22 | -282.36 | Upgrade |
Proceeds from Sale of Investments | 696.06 | 680.39 | 1,090 | 1,205 | 529.27 | 198.6 | Upgrade |
Payments for Business Acquisitions | - | - | - | - | 0.62 | - | Upgrade |
Investing Cash Flow | -144.52 | 185.01 | 71.84 | -461.34 | -294.14 | -100.12 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 3.27 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | - | -1.57 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | - | 1.7 | Upgrade |
Issuance of Common Stock | 6.16 | 8.22 | 279.33 | 114.07 | 767.08 | 322.68 | Upgrade |
Net Common Stock Issued (Repurchased) | 6.16 | 8.22 | 279.33 | 114.07 | 767.08 | 322.68 | Upgrade |
Other Financing Activities | - | -0.49 | -2.88 | -2.48 | -10.93 | -2.06 | Upgrade |
Financing Cash Flow | 479.19 | 7.74 | 276.45 | 111.59 | 756.14 | 322.32 | Upgrade |
Net Cash Flow | -10.15 | -154.5 | 199.09 | -327.22 | 395.73 | 126.46 | Upgrade |
Beginning Cash & Cash Equivalents | 298.92 | 444.61 | 245.52 | 572.74 | 177.01 | 50.55 | Upgrade |
Ending Cash & Cash Equivalents | 288.77 | 290.11 | 444.61 | 245.52 | 572.74 | 177.01 | Upgrade |
Free Cash Flow | -355.57 | -356.19 | -182.93 | -26.42 | -113.08 | -112.1 | Upgrade |
FCF Margin | -589.95% | -560.77% | -48.43% | -43.37% | -218.11% | -467075.00% | Upgrade |
Free Cash Flow Per Share | -4.00 | -4.33 | -2.37 | -0.38 | -1.76 | -2.40 | Upgrade |
Levered Free Cash Flow | -455.73 | -464.32 | -253.04 | -389.33 | 1.26 | -200.45 | Upgrade |
Unlevered Free Cash Flow | -503.12 | -503.19 | -298.83 | -417.66 | -20.57 | -139.04 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.